Quadria Capital Investment Management
Quadria Capital Investment Management is a venture capital firm in Singapore, Singapore, investing at Series A, Series C and Series F in Asia backing healthcare companies, with $4.7B AUM. It has an estimated $399.4M in dry powder and a cheque size of $4.5M–$41.6M. Its latest deals were Apex Healthcare Berhad (—, Nov 2025), Aragen Life Sciences Pvt. Ltd. (—, Jan 2025) and NephroPlus (Series F, May 2024).
See if Quadria Capital Investment Management fits your roundIs your startup a good fit for Quadria Capital Investment Management?
Est. dry powder
$399.4M
Raised, not yet invested
AUM
$4.7B
Assets under management
Latest fund
$594.3M
Quadria Capital Fund II
Est. cheque size
$4.5M–
From fund sizes
Deals, last 12 months
1
Last seen investing Nov 2025
About Quadria Capital Investment Management
Quadria Capital Investment Management is a private equity firm based in Singapore. The firm invests in the healthcare sector across the South Asia and Southeast Asia regions.
- Type
- Venture Capital Firm
- Headquarters
- Singapore, Singapore
- Stages
- Series ASeries CSeries FEarly Stage
- Est. cheque size
- $4.5M–$41.6M
- Sectors
- Healthcare
- Regions
- Asia
- Strategies
- Growth
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- —23
- Series A2
- Series C2
- Series F1
Across 31 deals
Portfolio sectors
- Healthcare10
- Pharmaceuticals6
- Medical Devices & Equipment3
- Biotechnology2
- Consumer Products1
Across 27 companies
Portfolio countries
- India18
- Malaysia3
- Indonesia2
- Singapore2
- Vietnam2
Across 27 companies
Recent investments
Newest 5 of 31
- —$454.3M
Apex Healthcare Berhad
Nov 2025 · —
- —$100M
Aragen Life Sciences Pvt. Ltd.
Jan 2025 · —
- Series F$101.9M
NephroPlus
May 2024 · Series F
- Series C$18M
Medi Assist Healthcare Services Limited
Aug 2023 · Series C
- —$73.1M
Maxivision Eye Hospitals Private Limited
Jul 2023 · —
Offices
4 locations
- Singapore, SingaporeHQ
- Ho Chi Minh City, Vietnam
- New Delhi, Delhi, India
- Jakarta, Indonesia